Paradigm Biocapital Advisors LP - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 225 filers reported holding MIRATI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 1.1%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$90,658,065
+24.8%
1,543,116
-7.5%
4.24%
-13.9%
Q3 2023$72,663,133
+39.3%
1,668,116
+15.5%
4.93%
+22.3%
Q2 2023$52,163,121
+0.4%
1,443,762
+3.4%
4.03%
-18.1%
Q1 2023$51,932,243
-9.6%
1,396,779
+10.2%
4.92%
-27.0%
Q4 2022$57,451,721
-3.3%
1,267,970
+49.1%
6.74%
-14.8%
Q3 2022$59,391,000
+34.1%
850,385
+28.9%
7.92%
-10.4%
Q2 2022$44,304,000
+447.7%
659,968
+570.8%
8.83%
+313.0%
Q1 2022$8,089,000
-78.8%
98,383
-62.2%
2.14%
-80.4%
Q4 2021$38,156,000260,11510.90%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 1,992,085$10,877,0008.55%
Boxer Capital, LLC 757,935$4,138,0003.67%
Avoro Capital Advisors LLC 1,214,833$6,633,0001.47%
Broadfin Capital, LLC 693,863$3,788,0000.37%
ACUTA CAPITAL PARTNERS, LLC 125,000$683,0000.33%
RTW INVESTMENTS, LP 131,052$716,0000.24%
SPHERA FUNDS MANAGEMENT LTD. 150,000$819,0000.21%
QVT Financial LP 509,750$2,783,0000.19%
Baker Brothers Advisors 2,269,198$12,390,0000.13%
Ghost Tree Capital, LLC 75,000$410,0000.12%
View complete list of MIRATI THERAPEUTICS INC shareholders